Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
A noncanonical cytoplasmic role for BUB1 in restraining DNA damage-induced dsRNA accumulation and sensing within stress granules.
Journal: Science immunology
Published: August 08, 2025
DGAT1 Inhibition Induces Ferroptosis and Enhances Cancer Immunotherapy Efficacy.
Journal: Cancer research
Published: February 21, 2025
Time to Mobility Is Associated With Pulmonary Complications in Patients With Spine Fractures.
Journal: The American surgeon
Published: April 03, 2024
VHL loss enhances antitumor immunity by activating the anti-viral DNA-sensing pathway.
Journal: iScience
Published: February 02, 2024
Targeting Catechol-O-Methyltransferase Induces Mitochondrial Dysfunction and Enhances the Efficacy of Radiotherapy in Glioma.
Journal: Cancer research
Published: January 13, 2024
VHL loss enables immune checkpoint blockade therapy by boosting type I interferon response.
Journal: bioRxiv : the preprint server for biology
Published: December 11, 2023
SETDB1 Restrains Endogenous Retrovirus Expression and Antitumor Immunity during Radiotherapy.
Journal: Cancer research
Published: October 17, 2021
ATM inhibition enhances cancer immunotherapy by promoting mtDNA leakage and cGAS/STING activation.
Journal: The Journal of clinical investigation
Published: April 20, 2020
Endogenous Retrovirus Activation as a Key Mechanism of Anti-Tumor Immune Response in Radiotherapy.
Journal: Radiation research
Published: February 20, 2020
ATM Paradoxically Promotes Oncogenic Transformation via Transcriptional Reprogramming.
Journal: Cancer research
Published: July 22, 2019
Inhibition of PCSK9 potentiates immune checkpoint therapy for cancer.
Journal: Nature
Published: December 24, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026